{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:47Z","timestamp":1791355847439,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.clml.2014.02.011","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T02:31:13Z","timestamp":1393813873000},"page":"468-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Role of GAS5 Noncoding RNA in Mediating the Effects of Rapamycin and Its Analogues on Mantle Cell Lymphoma Cells"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8324-1325","authenticated-orcid":false,"given":"Mirna","family":"Mourtada-Maarabouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyn T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2014.02.011_bib1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3109\/10428194.2012.726719","article-title":"Current and emerging new treatment strategies for mantle cell lymphoma","volume":"54","author":"Humala","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2014.02.011_bib2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1586\/era.12.99","article-title":"Emerging agents for the treatment of mantle cell lymphoma","volume":"12","author":"Camara-Clayette","year":"2012","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1016\/j.clml.2014.02.011_bib3","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.biocel.2007.04.026","article-title":"The cellular origin of mantle cell lymphoma","volume":"39","author":"Bertoni","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1179\/102453310X12647083620840","article-title":"Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis","volume":"15","author":"Li","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2014.02.011_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(88)91065-3","article-title":"Genes specifically expressed at growth arrest of mammalian-cells","volume":"54","author":"Schneider","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.clml.2014.02.011_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00262-003-0476-6","article-title":"The use of gene function to identify the rate-limiting steps controlling cell fate","volume":"53","author":"Williams","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clml.2014.02.011_bib7","first-page":"255","article-title":"Isolation of genes controlling apoptosis through their effects on cell survival","volume":"10B","author":"Williams","year":"2006","journal-title":"Gene Ther Mol Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1242\/jcs.024646","article-title":"Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5)","volume":"121","author":"Mourtada-Maarabouni","year":"2008","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.clml.2014.02.011_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/hmg\/ddm375","article-title":"SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer","volume":"17","author":"Dong","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clml.2014.02.011_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1673-8527(08)60134-4","article-title":"Implication of snoRNA U50 in human breast cancer","volume":"36","author":"Dong","year":"2009","journal-title":"J\u00a0Genet Genomics"},{"key":"10.1016\/j.clml.2014.02.011_bib11","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/leu.2012.111","article-title":"Specific small nucleolar RNA expression profiles in acute leukemia","volume":"26","author":"Valleron","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2014.02.011_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrc3195","article-title":"Are snoRNAs and snoRNA host genes new players in cancer?","volume":"12","author":"Williams","year":"2012","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.clml.2014.02.011_bib13","doi-asserted-by":"crossref","first-page":"e1000507","DOI":"10.1371\/journal.pcbi.1000507","article-title":"Human miRNA precursors with box H\/ACA snoRNA features","volume":"5","author":"Scott","year":"2009","journal-title":"Plos Comput Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib14","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.biochi.2011.05.026","article-title":"From snoRNA to miRNA: dual function regulatory non-coding RNAs","volume":"93","author":"Scott","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.clml.2014.02.011_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/nar\/gkq776","article-title":"Human box C\/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs","volume":"39","author":"Brameier","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clml.2014.02.011_bib16","doi-asserted-by":"crossref","first-page":"ra8","DOI":"10.1126\/scisignal.2000568","article-title":"Noncoding RNA Gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor","volume":"3","author":"Kino","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.clml.2014.02.011_bib17","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1128\/MCB.18.12.6897","article-title":"Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes","volume":"18","author":"Smith","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/35104581","article-title":"7SK small nuclear RNA binds to and inhibits the activity of CDK9\/cyclin T complexes","volume":"414","author":"Nguyen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clml.2014.02.011_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1261\/rna.2528811","article-title":"SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer","volume":"17","author":"Askarian-Amiri","year":"2011","journal-title":"RNA"},{"key":"10.1016\/j.clml.2014.02.011_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/mol.110.064055","article-title":"Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5)","volume":"78","author":"Mourtada-Maarabouni","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.clml.2014.02.011_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1042\/BST0390482","article-title":"A\u00a0critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes","volume":"39","author":"Williams","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.clml.2014.02.011_bib22","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2014.02.011_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1586\/ehm.09.57","article-title":"Temsirolimus for the treatment of mantle cell lymphoma","volume":"2","author":"Hess","year":"2009","journal-title":"Exp Rev Hematol"},{"key":"10.1016\/j.clml.2014.02.011_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2141.1998.00911.x","article-title":"Establishment and characterization of a mantle cell lymphoma cell line","volume":"102","author":"Jeon","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.02.011_bib25","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2005-05-2013","article-title":"Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes","volume":"106","author":"Rubio-Moscardo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.02.011_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/excr.2000.4955","article-title":"Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation","volume":"259","author":"Bedner","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.clml.2014.02.011_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1097-0320(20010501)44:1<73::AID-CYTO1084>3.0.CO;2-S","article-title":"Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry","volume":"44","author":"Smolewski","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.clml.2014.02.011_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","article-title":"Immunopharmacology of rapamycin","volume":"14","author":"Abraham","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clml.2014.02.011_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1358\/dot.2007.43.10.1148059","article-title":"Temsirolimus","volume":"43","author":"Ma","year":"2007","journal-title":"Drugs Today"},{"key":"10.1016\/j.clml.2014.02.011_bib30","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clml.2014.02.011_bib31","doi-asserted-by":"crossref","first-page":"32547","DOI":"10.1074\/jbc.272.51.32547","article-title":"The mammalian target of rapamycin phosphorylates sites having a (Ser\/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus","volume":"272","author":"Brunn","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clml.2014.02.011_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcdb.2004.11.005","article-title":"mTOR, translational control and human disease","volume":"16","author":"Tee","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib34","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1046\/j.1432-1327.2000.01719.x","article-title":"Synthesis of the translational apparatus is regulated at the translational level","volume":"267","author":"Meyuhas","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.clml.2014.02.011_bib35","first-page":"7358","article-title":"Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation-factor 4e","volume":"13","author":"Rosenwald","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clml.2014.02.011_bib36","first-page":"1343","article-title":"Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis","volume":"20","author":"Zimmer","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clml.2014.02.011_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/372570a0","article-title":"Interleukin-2-mediated elimination of the P27(kip1) cyclin-dependent kinase inhibitor prevented by rapamycin","volume":"372","author":"Nourse","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.clml.2014.02.011_bib38","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:26Z","timestamp":1761870386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265014000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2152265014000536"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.02.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of GAS5 Noncoding RNA in Mediating the Effects of Rapamycin and Its Analogues on Mantle Cell Lymphoma Cells","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}